BAC vs MRK: Which Is the Better Buy?
Side-by-side comparison of Bank of America Corporation and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-14.
Bank of America Corporation · Financial Services
$59.50
-45.0% upside to fair value
Grade C
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
MRK has more upside to fair value
(-12.1%).
BAC trades at a lower forward P/E
(14.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BAC |
MRK |
| Current Price |
$59.50 |
$113.87 |
| Fair Value Estimate |
$32.73 |
$100.14 |
| Upside to Fair Value |
-45.0%
|
-12.1%
|
| Market Cap |
$422.2B |
$281.2B |
| Forward P/E |
14.6x
|
32.0x
|
| EV / EBITDA |
13.3x
|
17.3x
|
| Price / Sales |
2.4x
|
4.3x
|
| Price / FCF |
7.5x
|
19.9x
|
| Revenue Growth YoY |
-35.6%
|
+4.3%
|
| Gross Margin |
63.2%
|
75.9%
|
| Operating Margin |
22.9%
|
27.6%
|
| Return on Equity |
10.5%
|
17.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
13.4%
|
5.02%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Bank of America Corporation operates as a diversified bank within the financial services sector, offering a broad range of banking and financial products. The business quality is medium, supported by a 10.5% return on equity and solid margins, but recent revenue declined sharply by 35.6% in the most recent quarter, indicating top-line pressure. Despite earnings growth of 16.1% in the same period,…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
BAC |
MRK |
| Zone Low |
$24.55 |
$75.11 |
| Zone High |
$27.82 |
$85.12 |
| In Buy Zone? |
No
|
No
|